Top Markets
#1 Black Phoenix Black Phoenix +360.67%
#2 Islamic Coin Islamic Coin +158.11%
#3 Glidr Glidr +84.34%
#4 Gold Park Gold Park +56.31%
#5 Akedo Akedo +47.69%
#6 BasedHype BasedHype +32.33%
#7 Acurast Acurast +28.67%
#8 Cryptopia Cryptopia +22.04%
#9 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.69%
#10 Quantum Resistant Ledger Quantum Resistant Ledger +17.37%
Coin of the day
Black Phoenix Black Phoenix
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Quick-Med Technologies, Inc. Quick-Med Technologies, Inc.

Quick-Med Technologies, Inc.

QMDT
Rang in Aktien #41276
Quick-Med Technologies, Inc. focuses on sustainable antimicrobial technologies.... Quick-Med Technologies, Inc. focuses on sustainable antimicrobial technologies. It provides treatment optimization, laboratory prototyping to factory scale-up, domestic and international regulatory guidance, microbiological efficacy testing including viruses, patent expertise, technology evaluations, antimicrobials market evaluations, and scientific invention and original research products. The company’s core technologies include Nimbus, a non-leaching antimicrobial wound dressing material; Stay Fresh, a sequestered hydrogen peroxide-based antimicrobial technology; and superabsorbent antimicrobial materials. In addition, it offers bioguard, DriGo-HP, antimicrobial care products, antimicrobial textiles, and antimicrobial paints and coatings products. Quick-Med Technologies, Inc. was incorporated in 1997 and is headquartered in Gainesville, Florida.
Aktienkurs
$0.0008
Zuletzt synchronisiert: 2026-08-11
Marktkapitalisierung
$29.88K
Veränderung (1 Tag)
0.00%
Veränderung (1 Jahr)
700.00%
Land
US
Handel Quick-Med Technologies, Inc. (QMDT)

Kategorie

Healthcare
P/B-Verhältnis für Quick-Med Technologies, Inc. (QMDT)
P/B-Verhältnis zum 2026 TTM: 0
Laut den neuesten Finanzberichten und dem Aktienkurs von Quick-Med Technologies, Inc. beträgt das aktuelle Kurs-Buchwert-Verhältnis (TTM) 0. Am Ende des Jahres 2026 lag das P/B-Verhältnis bei 0.
P/B-Verlauf für Quick-Med Technologies, Inc. von 2026 bis 2026
P/B-Verhältnis zum Jahresende
Jahr P/B-Verhältnis ändert
Nicht genügend Daten für die angegebenen Daten.
P/B-Verhältnis für ähnliche Unternehmen oder Wettbewerber
Unternehmen P/B-Verhältnis P/B-Verhältnis-Differenz Land
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
 3.6634 -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
 - -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
 - -
FR
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
 - -
IT
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
 17.0941 -
US